All stock lists
Cryo Cell International Inc (CCEL)
NYSE: CCEL · Real-Time Price · USD
Healthcare · Medical Care Facilities
4.96+0.51 (+11.34%)
Insider Score
––Not scored
CCEL Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CCEL Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 |
| Revenue | 7.82 M | 7.78 M | 7.68 M | 7.84 M | 7.83 M | 7.93 M |
| Revenue Growth (YoY) | -0.02 % | -1.93 % | -3.59 % | -2.26 % | -2.99 % | -1.42 % |
| Cost of Revenue | 1.61 M | 1.86 M | 1.66 M | 1.73 M | 1.80 M | 1.86 M |
| Gross Profit | 6.21 M | 5.92 M | 6.03 M | 6.11 M | 6.02 M | 6.07 M |
| SG&A Expense | 3.78 M | 4.62 M | 5.01 M | 5.45 M | 3.88 M | 4.26 M |
| R&D Expense | 53.62 K | 99.78 K | 65.76 K | 84.78 K | 61.63 K | 131.71 K |
| Operating Expenses | 4.02 M | 4.72 M | 5.26 M | 10.08 M | 4.12 M | 4.58 M |
| Operating Income | 2.19 M | 1.20 M | 765.13 K | -3.97 M | 1.90 M | 1.49 M |
| Pretax Income | 1.83 M | 827.78 K | 70.31 K | -4.63 M | 1.19 M | 575.10 K |
| Tax Provision | 554.96 K | 273.19 K | 23.20 K | 58.64 K | -436.59 K | 219.32 K |
| Net Income | 1.27 M | 554.59 K | 47.11 K | -4.69 M | 1.62 M | 355.79 K |
| EPS (Basic) | 0.16 | 0.07 | 0.01 | -0.46 | 0.09 | 0.04 |
| EPS (Diluted) | 0.16 | 0.07 | 0.01 | -0.46 | 0.09 | 0.04 |
| Shares Outstanding | 8.06 M | 8.06 M | 8.06 M | 8.07 M | 8.06 M | 8.08 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.